Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study.
Furgier A, Brehin C, Levy C, Basmaci R, Launay E, Jung C, Assad Z, Lenglart L, Naudin J, Mary AL, Aupiais C, de Pontual L, Biran V, Boutillier B, Hau I, Shum M, Biscardi S, Delestrain C, Toubiana J, Cohen JF, Lambert-Hoffert A, Lorrot M, Romain AS, Ashman M, Yang JS, Prevost B, Corvol H, Basse C, Dubos F, Cotillon M, Bridonneau C, Perceval LM, Bizot E, Fafi I, Portefaix A, Domitien L, Jaillet C, Ouziel A, Titomanlio L, Bechet S, Gajdos V, Gras-Le Guen C, Gillet Y, Cohen R, Jeziorski E, Ouldali N; French Paediatric OVNI Network.
Furgier A, et al.
Lancet Reg Health Eur. 2025 Sep 10;58:101443. doi: 10.1016/j.lanepe.2025.101443. eCollection 2025 Nov.
Lancet Reg Health Eur. 2025.
PMID: 41220615
Free PMC article.